$794.190
-13.263 (-1.67%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
REGN Prediction & Forecast by Similar Chart Analysis
Alphio's REGN stock price prediction model matches the current Regeneron Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $799.91 (+0.72%). The 1-week path is $796.41 (+0.28%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Regeneron Pharmaceuticals Inc Stock?
Regeneron Pharmaceuticals Inc is currently not a good buy due to recent negative catalysts, including a significant trial failure that resulted in an $11 billion market cap loss. The current price is $794.19, which is below the average analyst target of $795, indicating limited upside potential. Additionally, the RSI is at 35.243, suggesting the stock is oversold, but the recent 5-day change of -4.78% raises concerns about further declines.
REGN stock price ended at $794.19 on Friday, after losing -1.67%
Regeneron Pharmaceuticals Inc (REGN) last closed at $794.19, losing -1.67%. These facts feed the 1-day and 1-week REGN price prediction above.
Analyst Consensus
Regeneron Pharmaceuticals Inc (REGN): 13 buy, 12 hold, 1 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Regeneron Pharmaceuticals Inc (REGN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches REGN, ranked by similarity.
Seasonality analysis for REGN
Historically the probability of a positive August return for REGN is 60.32%. February offers the highest probability of a positive month at 60.34%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for REGN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $464.93 | $554.28 | $680.11 | -30.21% |
| Sep 2026 | $655.63 | $707.69 | $735.54 | -10.89% |
| Oct 2026 | $532.77 | $606.87 | $618.10 | -23.59% |
| Nov 2026 | $582.01 | $654.23 | $691.74 | -17.62% |
| Dec 2026 | $606.44 | $711.92 | $785.14 | -10.36% |
In 2026, Regeneron Pharmaceuticals Inc (REGN) is projected to range from $464.93 to $785.14.
Regeneron Pharmaceuticals Inc 2026 monthly forecast
In Aug 2026, Regeneron Pharmaceuticals Inc is projected to average $554.28, with a low of $464.93 and high of $680.11.
In Sep 2026, Regeneron Pharmaceuticals Inc is projected to average $707.69, with a low of $655.63 and high of $735.54.
In Oct 2026, Regeneron Pharmaceuticals Inc is projected to average $606.87, with a low of $532.77 and high of $618.10.
In Nov 2026, Regeneron Pharmaceuticals Inc is projected to average $654.23, with a low of $582.01 and high of $691.74.
In Dec 2026, Regeneron Pharmaceuticals Inc is projected to average $711.92, with a low of $606.44 and high of $785.14.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。